切换至 "中华医学电子期刊资源库"

中华妇幼临床医学杂志(电子版) ›› 2007, Vol. 03 ›› Issue (05) : 261 -263. doi: 10.3877/cma.j.issn.1673-5250.2007.05.107

论著

中枢神经系统感染患儿脑脊液和血清补体C3,C4及C-反应蛋白检测的临床意义
王西蓉, 杨尧, 边程鹏, 石艳, 谢永国, 徐嘉莉, 简和, 王晓曦   
  1. 四川省凉山州第一人民医院儿科(西昌,615000)
  • 出版日期:2007-10-01

Clinical meaning about assay the complement C3,C4 and C-reactive protein in cerebrospinal fluid and serum of children′s central nervous system infection

Xi-rong WANG, Yao YANG, Cheng-peng BIAN, Yan SHI, Yong-guo XIE, Jia-li XU, He JIAN, Xiao-xi WANG   

  1. Department of Pediatrics, NO.1 People′s Hospital of Liangshan, Xichang 615000, China
  • Published:2007-10-01
引用本文:

王西蓉, 杨尧, 边程鹏, 石艳, 谢永国, 徐嘉莉, 简和, 王晓曦. 中枢神经系统感染患儿脑脊液和血清补体C3,C4及C-反应蛋白检测的临床意义[J/OL]. 中华妇幼临床医学杂志(电子版), 2007, 03(05): 261-263.

Xi-rong WANG, Yao YANG, Cheng-peng BIAN, Yan SHI, Yong-guo XIE, Jia-li XU, He JIAN, Xiao-xi WANG. Clinical meaning about assay the complement C3,C4 and C-reactive protein in cerebrospinal fluid and serum of children′s central nervous system infection[J/OL]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2007, 03(05): 261-263.

目的

探讨脑脊液补体C3,C4及C-反应蛋白(C-reactive protein,CRP)检测,对中枢神经系统感染患者病因的鉴别诊断意义及脑脊液补体C3,C4与血清补体C3,C4的关系。

方法

采用速率散射比浊法测定38例病毒性脑炎(A组)、10例化脓性脑膜炎(B组)、18例结核性脑膜炎(C组)及22例非中枢神经系统感染(对照组)患者脑脊液及血清补体C3,C4及C-反应蛋白含量,并进行对比分析。

结果

①B组、C组、A组、对照组脑脊液C3阳性率分别为100.00%,88.88%,5.20%,0;脑脊液C4阳性率分别为80.00%,44.44%,0,0。B组、C组与A组及对照组脑脊液C3,C4比较,差异有显著意义(P<0.01);C组与B组、A组及对照组脑脊液C3,C4比较,差异无显著意义(P>0.05);②血清C3,C4检测结果显示,各组均在正常参考范围内,组间比较,差异无显著意义(P>0.05),与同组脑脊液C3,C4无正相关。③B组、C组脑脊液CRP值和血清CRP值与A组及对照组比较,显著增高(P<0.01);B组与C组比较,差异无显著意义(P>0.05);A组与对照组比较,差异无显著意义(P>0.05)。

结论

脑脊液补体C3,C4,CRP及血清CRP值,对细菌性脑膜炎与病毒性脑炎的鉴别诊断有很高的参考价值。脑脊液补体C3,C4与血清中补体C3,C4无明显相关性。

Objective

To clarify the meaning of distinguish and diagnose the pathogensis about children′s central nervous system infection(CNSI) through assaying the content of C3, C4 and C-reactive protein (CRP) in cerebrospinal fluid (CSF) and the relationship of complement C3, C4 in CSF and serum of CNSI.

Methods

Use the rate nephelometry assay the patients′ complement C3, C4 and CRP in CSF and serum which existed in 38 cases of virus meningitis(VM) (group A), 10 cases of purulent meningitis (PM) (group B), 18 cases of tubercular meningitis(TM) (group C) and 22 cases of non-central nerve system infection(NCNSI) (control group).

Results

①The positive rate of C3 in CSF is 100%, 88.88%, 5.20% and 0 in group B, C, A and control group respectively. And C4 in CSF is 80.00%, 44.44%, 0 and 0 respectively. There is a significant difference between group B, C, A and control group (P<0.01). No significant difference was found between group C and B, also A and control group (P>0.05). ② The assay results of C3 and C4 in serum is in normal reference range.The comparison between two groups had no significant difference(P>0.05). There is no positive correlation between C3, C4 in CSF and C3, C4 in serum in the same group.③The value of CRP in CSF and serum group B and C is higher than that of A and control group (P<0.01). No significant difference was found between group B and C. Also there is no significant difference between group A and control group (P>0.05).

Conclusion

Complement C3, C4, CRP in CSF and CRP in serum have high referenced value upon distinguish and diagnose the virus meningitis and bacterial meningitis. Complement C3, C4 in CSF and complement C3, C4 in serum do not have significant relevance.

1 Stahel PF,Barnum ST.Bacterial meningitis: Complement gene expression in the central nervous system. Immunopharmacology,1997,38:65-72.
2 朱旭慧.中枢神经系统感染患儿脑脊液蛋白质检测的临床意义.中华医学杂志,2002,20:69-70.
3 Stahel PF, Frei K, Fontana A, et al. Evidence for intrathecal synthesis of alternative pathway complement activation proteins in experimental meningitis. J Am Path,1997,151:897-904.
4 李光乾.中枢神经系统感染患儿脑脊液补体C3,C4检测的临床意义.中华儿科杂志,2000,38:54-55.
5 王亚娟,胡翼云,杨永弘.C-反应蛋白在儿科临床的应用.中华儿科杂志,1999,37:185-187.
6 李招云.脑膜炎患者血清和脑脊液C-反应蛋白水平的变化.上海医学检验杂志,1999,14:210-211.
7 张秀明,刑广志.脑脊液蛋白质测定的临床应用新进展.上海医学检验杂志,1999,14:314.
8 乔雪亮.脑脊液CRP测定对3种脑膜炎诊断价值探讨.实用医技,2000,7:417.
9 宋彦文.脑脊液C-反应蛋白检测对化脓性脑膜炎的诊断价值.山东医药,1999,39:66.
[1] 农云洁, 黄小桂, 黄裕兰, 农恒荣. 超声在多重肺部感染诊断中的临床应用价值[J/OL]. 中华医学超声杂志(电子版), 2024, 21(09): 872-876.
[2] 许月芳, 刘旺, 曾妙甜, 郭宇姝. 多粘菌素B和多粘菌素E治疗外科多重耐药菌感染临床疗效及安全性分析[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 700-703.
[3] 梁孟杰, 朱欢欢, 王行舟, 江航, 艾世超, 孙锋, 宋鹏, 王萌, 刘颂, 夏雪峰, 杜峻峰, 傅双, 陆晓峰, 沈晓菲, 管文贤. 联合免疫治疗的胃癌转化治疗患者预后及术后并发症分析[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 619-623.
[4] 皮尔地瓦斯·麦麦提玉素甫, 李慧灵, 艾克拜尔·艾力, 李赞林, 王志, 克力木·阿不都热依木. 生物补片修补巨大复发性腹壁切口疝临床疗效分析[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 624-628.
[5] 顾熙, 徐子宇, 周澍, 张吴楼, 张业鹏, 林昊, 刘宗航, 嵇振岭, 郑立锋. 腹股沟疝腹膜前间隙无张力修补术后补片感染10 例报道[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 665-669.
[6] 臧宇, 姚胜, 朱新勇, 戎世捧, 田智超. 低温等离子射频消融治疗腹壁疝术后补片感染的临床效果[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 687-692.
[7] 杨闯, 马雪. 腹壁疝术后感染的危险因素分析[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 693-696.
[8] 井发红, 李丽娜, 高婷, 高艳梅, 杨楠, 李卓, 慕玉东. 肺癌立体定向放疗血清SAP 和MMPs 表达及临床意义[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 707-713.
[9] 邢嘉翌, 龚佳晟, 祝佳佳, 陆群. 肺癌化疗患者继发肺部感染的病原菌耐药性及炎症因子变化分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 714-718.
[10] 中华医学会器官移植学分会. 肝移植术后缺血性胆道病变诊断与治疗中国实践指南[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 739-748.
[11] 贾玲玲, 滕飞, 常键, 黄福, 刘剑萍. 心肺康复在各种疾病中应用的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 859-862.
[12] 颜世锐, 熊辉. 感染性心内膜炎合并急性肾损伤患者的危险因素探索及死亡风险预测[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 618-624.
[13] 杨菲, 刘腾飞, 赵志军, 李睿聪, 张颉, 刘妍, 赵珍. 血清维生素水平与分化型甲状腺癌的关联性研究[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 633-640.
[14] 王子阳, 王宏宾, 刘晓旌. 血清标志物对甲胎蛋白阴性肝细胞癌诊断的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 677-681.
[15] 李兰兰, 龚忆华, 陈泳欣, 郑纯翠, 易石坚. 失效模式和效果分析模式提高医院保洁人员标准预防依从性的效果[J/OL]. 中华卫生应急电子杂志, 2024, 10(05): 277-280.
阅读次数
全文


摘要